Expanding the clinicopathological spectrum of TGFBR3‐PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high‐grade transformation

Abstract

PLAG1 rearrangements have been described as a molecular hallmark of salivary gland pleomorphic adenoma (PA), carcinoma ex pleomorphic adenoma (CEPA), and myoepithelial carcinoma (MECA). Several fusion partners have been described, however, commonly no further assignment to the aforementioned entities or a morphological prediction can be made based on the knowledge of the fusion partner alone. In contrast, TGFBR3‐PLAG1 fusion has been specifically described and characterized as an oncogenic driver in MECA, and less common in MECA ex PA. Here, we describe the clinicopathological features of three TGFBR3‐PLAG1 fusion‐positive salivary gland neoplasms, all of which arose in the deep lobe of the parotid gland. Histopathology showed high morphological similarities, encompassing encapsulation, a polylobular growth pattern, bland basaloid and oncocytoid cells with myoepithelial differentiation, and a distinct sclerotic background. All cases showed at least limited, unusual foci of minimal invasion into adjacent salivary gland tissue, including one case with ERBB2 (Her2/neu) amplified, TP53 mutated high‐grade transformation, and lymph node metastases. Of note, all cases illustrated focal ductal differentiation. Classification remains difficult, as morphological overlaps between myoepithelial‐rich cellular PA, myoepithelioma, and MECA were observed. However, evidence of minimal invasion advocates classification as low‐grade MECA. This case series further characterizes the spectrum of uncommon cellular myoepithelial neoplasms harboring TGFBR3‐PLAG1 fusion, which show recurrent minimal invasion of the adjacent salivary gland tissue, a predilection to the deep lobe of the parotid gland, and potential high‐grade transformation.

The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative

“…Primary tumors of the salivary gland show a wide variety of morphologic entities, with additional subtypes continuously being described 3,4 . This histologic diversity leads to challenges in the data‐driven management of salivary gland malignancies 5–8 . The two most significant prognostic factors are histologic tumor grade and the clinical stage at presentation 9–11 …”

“…3,4 This histologic diversity leads to challenges in the data-driven management of salivary gland malignancies. [5][6][7][8] The two most significant prognostic factors are histologic tumor grade and the clinical stage at presentation. [9][10][11] Treatment of primary salivary gland malignancies usually includes surgical resection followed by postoperative radiation therapy for high-grade histology and/or advanced-stage disease.…”

Molecular testing in salivary gland cytopathology: A practical overview in conjunction with the Milan system

“…70 TGFBR3::PLAG1 gene fusion seems to be associated with a greater degree with atypical myoepithelial neoplasms. 28,29…”

Updates in head and neck cytopathology: Insights from European Congress of Pathology Short Course

“…However, it should be noted that myoepitheliomas, 16 myoepithelial carcinomas, 17,18 and carcinomas ex PA 19 can also show identical PLAG1 (or HMGA2) gene fusions, so that monophasic, myoepithelial neoplasms are more difficult to classify.…”